) were examined for pap n p 73 genotype and P fimbrial expression in relation to bacteremia and patients' background variables. + or pap Ϫ strains and were older, and most had compromising conditions. papG IA2 + strains predominated among patients with medical illness, whereas prsG J96 + strains predominated among patients with urinary tract abnormalities. These findings emphasize the strong influence of host factors on the selection of E. coli strains causing febrile urinary tract infections.
febrile UTIs [1] [2] [3] [4] , but few patients develop septic shock [3] .
Epidemiological studies have shown that acute pyelonephritis is caused by uropathogenic Escherichia coli clones belonging to certain O:K:H (somatic [O] , capsular [K] , and flagellar [H] antigens) serotypes and with chromosomal pathogenicity islands that encode multiple virulence factors [5] [6] [7] [8] [9] [10] . Bacteremia is caused by a subset of these clones that express P fimbriae more often than strains causing less severe forms of UTI [1, 2, 6, 7, [11] [12] [13] [14] [15] [16] .
Two P fimbrial subtypes predominate among uropathogenic E. coli. They differ in terms of the G adhesin at the tip of the fimbrial organelle, with slight variations in receptor specificity [17] [18] [19] [20] . The class II G adhesins encoded by the papG IA2 sequences are associated with pyelonephritis and bacteremia [1, 13, 14, 21] . The class III G adhesins encoded by the prsG J96 sequences are associated with cystitis but have been found in pyelonephritis and bacteremia [1, [13] [14] [15] 21] . The virulence of E. coli strains causing febrile UTI and bacteremia is influenced by host compromise, a term denoting concomitant diseases in the patient. Host compromise allows less-virulent strains to cause infection [1-3, 7, 11-13] , and P fimbrial strains are less common in compromised patients with bacteremia (52%-68%). Few studies have addressed the influence of host compromise on the presence of G adhesins, especially the prsG J96 adhesin [1, 13] . Earlier studies on P fimbriation, pap genotype, and bacteremia were retrospective or involved selected patient groups.
This study examined the pap and papG genotypes and the P fimbrial expression in a prospectively enrolled, unselected patient population with febrile UTIs. The findings emphasize the influence of host compromise, sex, and age on the papG allele of the infecting strain.
PATIENTS AND METHODS

Patients.
Seventy-three patients with febrile E. coli UTIs were enrolled in a prospective study [4] . The patients were 18-85 years old and had clinically diagnosed febrile UTIs requiring hospitalization and parenteral antibiotic therapy. Their temperatures were у38ЊC at the time of admission, and they had focal symptoms involving the urinary tract (flank pain, costovertebral angle tenderness, dysuria, or urinary frequency or urgency); laboratory findings of a positive result on a nitrite test or increased urine leukocyte counts; and/or urinary tract instrumentation or acute urinary retention preceding the onset of fever. All patients had significant bacteriuria at admission. Patients were assigned to the bacteremic group if the result of у1 blood culture was positive and the same bacterial species was recovered from the blood and urine. The patients were hospitalized, treated, and followed for 4 months after therapy.
The patients represent a subset of the entire study sample of 97 patients. Eighty-three of those 97 patients had E. coli infections, and the E. coli strains from 73 patients were saved. Forty women and 33 men were included; the median age was 49 and 68 years, respectively. Bacteremia was diagnosed for 24 patients (33%): 15 women (38%) and 9 men (27%). The bacteremic patients were older but did not differ with regard to sex or host compromise from those without bacteremia (table  1) . The urinary tracts of 66 of the 73 patients were evaluated by iv pyelography or ultrasonography.
Host compromise. Forty-six patients (63%) with compromising conditions were assigned to 2 subgroups: those with medical illness ( ; 12 women, 5 men) and those with n p 17 urinary tract abnormalities ( ; 5 women, 24 men) (table n p 29 1). Eight patients with medical illness and urinary tract abnormalities were assigned to the first subgroup. Twenty-seven patients were healthy.
Patients assigned to the medical illness group had diseases or had received therapies that might influence the resistance to UTI (table 1) . Patients assigned to the urinary tract abnormalities group had a history of noninfectious urinary tract disease and/or structural abnormalities of the urinary tract, confirmed by iv pyelography, ultrasonography, or urological examination (table 1) . Noncompromised patients were younger (median age of 45 years vs. median age of 69 years among compromised patients), and 85% were women, whereas men predominated in the compromised group (63%). The 4 men designated as healthy were !50 years old and presented with fever (temperature, 38.4ЊC-39.7ЊC), lower urinary tract symptoms, C-reactive protein level 1130 mg/dL, and leukocytosis. They were all examined by pyelography and followed for 4 months, and no signs of compromising conditions were noted.
The frequency of bacteremia did not differ between compromised and noncompromised patients (30% vs. 35%; not significant [NS] ) or between patients with medical illness and those with urinary tract abnormalities (53% vs. 24%; NS).
Urine and blood cultures. Cultures of urine and blood samples were performed at the time of enrollment [4] . Significant bacteriuria was defined by growth of a single bacterial [15, 24] are indicated by white bars. Numbers signify the position of the first and last base in the amplified sequence. B, Primer sequences, positions, and length of the PCR products. C, Specificity of PCR reactions with the primers defined in B. The control strains Escherichia coli J96 and E. coli IA2 carried the prsG J96 and the papG IA2 sequences, respectively. The clinical isolate E. coli U33468 carried both the papG IA2 and the prsG J96 sequences, and the clinical isolate E. coli U22728 carried the papG IA2 sequence. E. coli HB101 was the negative control.
species at у10
4 cfu/mL in women and у10 3 cfu/mL in men [22] .
Serotyping of E. coli. The O, K, and H antigens of the E. coli isolates were determined using antisera to 165 O antigens, 72 K antigens, and 53 H antigens [23] . Nontypeable antigens were defined as ON, KN, and HN. Strains with no demonstrable capsule were designated as K Ϫ , nonmotile cultures as H Ϫ , and rough strains as Oru. P fimbrial phenotype. The P fimbrial phenotype was defined by P blood group-dependent hemagglutination [14] , after in vitro passage to enhance expression. Strains that agglutinated P 1 erythrocytes in an ABH blood group-independent manner were assigned to class II. Strains agglutinating only A 1 P 1 ϩ and not OP 1 ϩ erythrocytes were assigned to class III.
pap Genotype.
The pap genotype was determined by DNA-DNA hybridization, with probes specific for the 5 (HindIII) and 3 (SmaI) regions of the pap operon and derived from the pap gene cluster of E. coli J96 [14] .
papG genotype. The papG genotypes were defined by PCR, using primer pairs that matched unique regions of the papG IA2 or prsG J96 sequences (figure 1). P fimbrial E. coli IA2 and E. coli J96 and pap ϩ recombinants E. coli HB101 (papG IA2 ) and E. coli HB101 (prsG J96 ) were used as positive controls, and E. coli HB101 and E. coli AAEC191A(pPKL4) were used as negative controls. Primers amplifying the fimA gene were used to control the yield of bacterial DNA. Whole bacterial cells provided template DNA. The reaction mixture (25 mL) contained 1ϫ PCR buffer (Perkin-Elmer), 5 mM MgCl 2 , 0.2 mM of each dNTP, 0.1 mg/mL bovine serum albumin, 0.5 mM of each primer, and 0.025 U/mL AmpliTaq Gold (Perkin-Elmer). The reaction mixture was denatured at 94ЊC for 10 min and amplified by 5 touchdown cycles of denaturing, annealing, and extension at 94ЊC for 1 min, 63ЊC-59ЊC for 1 min, and 72ЊC for 2 min, followed by 45 cycles of 94ЊC for 1 min, 58ЊC for 1 min, 72ЊC for 2 min, and final extension at 72ЊC for 7 min. The PCR products were separated by agarose gel electrophoresis (2.5%) with ethidium bromide and photographed under ultraviolet transillumination. Each strain was amplified with primers for papG IA2 or prsG J96 in separate tubes. Strains positive for papG IA2 or for prsG J96 were assigned to that genotype. The primers did not cross-amplify other papG sequences, as shown by the recombinant strains containing a single known copy of papG IA2 or prsG J96 .
Statistics. The Mann-Whitney U test and Fisher's exact test were used. A 2-tailed P value !.05 was considered statistically significant.
RESULTS
pap and papG genotypes of the clinical isolates. The majority ( , 70%) of the strains were pap ϩ , and all but one n p 51 carried the entire pap gene cluster, as shown by hybridization with both probes (table 2). The remaining 22 isolates did not hybridize with the pap DNA probes.
All the pap ϩ strains were papG ϩ by PCR. There were 33 papG IA2 ϩ strains, 15 prsG J96 ϩ strains, and 3 strains carrying both sequences (table 2) . Twenty-two strains were negative for pap and papG. P fimbrial expression. P fimbriae were expressed by 46 strains (63%; table 2), with 35 strains belonging to class II and 11 belonging to class III. Eight strains (11%) expressed P blood group-independent adhesins, as shown by agglutination of A 1 p erythrocytes. The remaining 26% of the strains did not express P fimbriae. Indeed, 87% of all prsG J96 ϩ isolates were from the group with urinary tract abnormalities.
Isolates from patients with medical illness or urinary tract abnormalities showed no difference in pap frequency, but pap G IA2 ϩ isolates were more common in the group with medical illness and prsG J96 ϩ in the group with urinary tract abnormalities.
The eight patients with both medical illness and urinary tract abnormalities did not differ, in terms of papG allele distribution, from other patients in the group with medical illness, but they differed significantly in this respect from the group with urinary tract abnormalities ( for both papG IA2 ϩ and P ! .05 prsG J96 ϩ ). isolates were from men. The women included in the study were younger and healthier (58%) than the men (12%), who had a high frequency of urinary tract abnormalities (73%). The difference in pap genotype distribution between women and men was dramatic in the noncompromised patient group (figure 3). papG IA2 ϩ strains were recovered from 92% of the women but none of the men ( ). The difference was less P ! .001 marked among compromised women and men who had a mixture of papG IA2 ϩ , prsG J96 ϩ , and pap Ϫ strains (NS), and no differences were found among patients with urinary tract abnormalities or among patients with medical illness.
DISCUSSION
This study examined the papG genotype and P fimbrial expression in E. coli isolates from patients with febrile UTIs. The pap and papG genotypes of the infecting E. coli strain were shown to vary with host compromise, sex, and age. P fimbrial E. coli of the papG IA2 genotype infected healthy women and patients with medical illness, whereas older men and patients with compromising conditions of the urinary tract carried prsG J96 ϩ E. coli or pap Ϫ strains. The findings confirmed the high frequency of pap ϩ and papG IA2 ϩ strains in bacteremic patients without compromising conditions. They also show that the host exerts a strong selective pressure on the pap genotype and the P fimbrial phenotype of strains causing febrile UTI. Analyses of pap genotype have developed to a great extent since the early use of large probes encompassing the pap J96 gene cluster [7, 25, 26] . papG-specific probes were used to investigate isolates from different types of UTIs and from the fecal flora [1, 14, 18, 27, 28] . Johnson et al. designed PCR primers specific for the different papG sequences and showed a high concordance with DNA hybridization [15, 24] . In the present study, papG genotyping was done by PCR with primers adjacent to and partially overlapping those used by Johnson et al. The papG primers gave a complete concordance with DNA hybridization, and all strains with amplified papG sequences could express P fimbriae after in vitro passage.
Previous studies of febrile UTI, P fimbriae, pap genotype, and host factors often were based on patient populations selected in terms of age, sex, host compromise, or bacteremia [1, 2, 11-13, 28, 29] . The present study had a prospective design and enrolled adult patients of both sexes with febrile UTIs who were in need of hospitalization, which indicated severe illness. The identification of host compromise was supplemented by observations made during the 4-month follow-up period. The results confirmed that host compromise has a strong influence on the pap genotype of strains causing bacteremia [1, 2, [11] [12] [13] and added information on papG. All noncompromised bacteremic patients carried papG IA2 ϩ isolates, but prsG J96 ϩ isolates caused bacteremia only in compromised patients. This confirmed a suggested association between prsG J96 ϩ isolates and host compromise in urosepsis [13] . The pap/papG genotype differed according to the type of host compromise. Patients with medical illness resembled the noncompromised group in papG allele distribution but had more pap Ϫ strains. Patients with urinary tract abnormalities also had pap Ϫ strains, confirming the association between P fimbriae-negative strains and host compromise [1, 3, 7, [11] [12] [13] ], but they also were shown to carry 87% of all prsG J96 ϩ strains.
The predominance of prsG J96 ϩ isolates among patients with urinary tract abnormalities is in agreement with recent findings in a study of young children [29] . Women are susceptible to UTIs throughout adult life. In contrast, UTIs in men are mainly restricted to men of advanced age, coinciding with, for example, increasing urinary tract obstructions due to prostatic hyperplasia [3, 30] . This sex-related difference in UTI susceptibility has been attributed to a variety of factors, including anatomic differences, but few suggestions have been made as to possible molecular mechanisms. The present study demonstrated a marked sex-related difference in papG allele distribution. Healthy women were infected with papG IA2 ϩ strains (92%), whereas men were infected with prs G J96 ϩ or pap Ϫ isolates. The mucosal receptor repertoire of men and women has not been compared, but the differential selection of papG genotypes may suggest that molecular differences in adhesion and receptor recognition determine mucosal interactions in women and men. Additional studies in larger populations may define these associations more clearly.
The pap/papG allele distribution did not differ between compromised women and compromised men. Because the majority of compromised patients were men and because most had urinary tract abnormalities, the prsG J96 ϩ strains appeared to have an association with sex. However, analysis of women with urinary tract abnormalities showed no difference in the distribution of papG alleles between those women and the men, suggesting that host compromise overruled the selective effect of sex. Urinary tract abnormalities appeared to facilitate infection with prsG J96 ϩ strains in women and in men and explained the age-correlated increase of prsG J96 ϩ strains in men.
To summarize, papG IA2 ϩ E. coli was the major uropathogen in women of all ages, the major cause of bacteremia in healthy women, and a frequent cause of bacteremia in women with compromising conditions. Men seldom developed febrile UTIs unless compromising conditions were present and had a less clear-cut pattern of papG allele selection. prsG J96 ϩ E. coli was a common uropathogen in men; it was associated with urinary tract abnormalities, and it caused bacteremia only in compromised patients. We conclude that host factors place a strong selective pressure on the establishment of uropathogenic E. coli and the selection of their virulence profiles.
